Similarly, CCL2 increased ALDH1A1 expression and activity in DCIS.com expressing control shRNA cells which were significantly decreased with CCR2-KD (Fig. 4E,F). This evidence concerns the gene CCR2 and ductal breast carcinoma in situ.